Wells Fargo
RNTX

Wells Fargo’s Rein Therapeutics RNTX Stock Holding History

Wells Fargo’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26 Buy
+20
New +$25 ﹤0.01% 6742
2025
Q3 		– Sell
-1,688
Closed -$2.36K – 7482
2025
Q2 		$2.36K Buy
1,688
+1,686
+84,300% +$3.04K ﹤0.01% 6200
2025
Q1 		$4 Buy
+2
New +$4 ﹤0.01% 6906
2024
Q4 		– Sell
-9,544
Closed -$33.8K – 7238
2024
Q3 		$33.8K Buy
+9,544
New +$25.5K ﹤0.01% 5491
2024
Q2 		– Sell
-31
Closed -$206 – 7575
2024
Q1 		$206 Buy
31
+4
+15% +$19 ﹤0.01% 6489
2023
Q4 		$82 Buy
27
+3
+13% +$6 ﹤0.01% 6817
2023
Q3 		$36 Hold
24
– – ﹤0.01% 7015
2023
Q2 		$43 Buy
24
+1
+4% +$2 ﹤0.01% 7098
2023
Q1 		$29 Hold
23
– – ﹤0.01% 7278
2022
Q4 		$55 Buy
23
+1
+5% +$3 ﹤0.01% 6980
2022
Q3 		$0 Hold
22
– – ﹤0.01% 7543
2022
Q2 		$0 Buy
22
+2
+10% +$18 ﹤0.01% 7662
2022
Q1 		$0 Hold
20
– – ﹤0.01% 7997
2021
Q4 		$0 Hold
20
– – ﹤0.01% 7948
2021
Q3 		$0 Sell
20
-3
-13% -$66 ﹤0.01% 7650
2021
Q2 		$1K Buy
23
+2
+10% +$50 ﹤0.01% 6763
2021
Q1 		$1K Buy
21
+14
+200% +$480 ﹤0.01% 6781
2020
Q4 		$0 Hold
7
– – ﹤0.01% 7142
2020
Q3 		$0 Buy
7
+4
+133% +$94 ﹤0.01% 7035
2020
Q2 		$0 Hold
3
– – ﹤0.01% 6944
2020
Q1 		$0 Buy
+3
New +$36 ﹤0.01% 6938
2018
Q2 		– Sell
-42
Closed -$7K – 6629
2018
Q1 		$7K Hold
42
– – ﹤0.01% 6015
2017
Q4 		$9K Buy
42
+26
+163% +$6.23K ﹤0.01% 5954
2017
Q3 		$4K Buy
+16
New +$4.01K ﹤0.01% 6083

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Wells Fargo's RNTX Position: Q1 2026 in Review

Wells Fargo opened a new position in Rein Therapeutics (RNTX) in Q1 2026: 20 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #6742 among its holdings. This is a return to the name: Wells Fargo previously reported a position in RNTX as recently as Q2 2025.

Wells Fargo first reported a position in RNTX in Q3 2017 and has held it in 24 quarters since. The position peaked at $33.8K in Q3 2024. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Wells Fargo held 20 shares of Rein Therapeutics worth $26 as of Q1 2026.
  • Rein Therapeutics was a new Wells Fargo position in Q1 2026.
  • Rein Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6742 holding.
  • Wells Fargo first reported a position in Rein Therapeutics in Q3 2017 and has held it in 24 quarters since.
  • Wells Fargo's Rein Therapeutics position peaked at $33.8K in Q3 2024.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.